
TSE:ZUH
This summary was created by AI, based on 1 opinions in the last 12 months.
The BMO EqWt US HthCare Hedged CAD (ZUH-T) is favored by experts for its equal-weight strategy, which minimizes concentration risk in mega-cap pharmaceutical companies. The healthcare sector is noted for its lower volatility, providing a diversifying buffer against the concentrated leadership seen in more volatile market indexes. Analysts praise the sector's defensive growth characteristics, complemented by steady demand and strong balance sheets, which allow it to withstand economic fluctuations. Furthermore, ongoing healthcare innovations driven by advancements in AI are expected to propel the sector's growth, making it an attractive investment over the long term. While the expert reviews indicate a unique approach with futures market exposure, the overall sentiment remains positive regarding the stock's potential.
This has more health care in it, rather than pharmaceuticals. FT AlphaDEX US Health Care (FHH-T) is a rule based ETF in the healthcare area, but they use the Russell 1000, drilling down a little bit more into some of the smaller and less recognizable companies. With this one he is not buying a US health care with an impoverished Cdn$.
US healthcare is one area that hasn’t been on people’s radar for quite a while but has been performing pretty well. Healthcare is typically one or 2 products that really drive the earnings of each company. This is an equal weighted ETF, so regardless of which company does well, as long as the overall sector does well it should do well.
He likes this because it is equal weighted and hedged against the decline in the US$. You can quite comfortably put this into your portfolio.